NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
231 Jönköping

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 489 4.1% 129 1.1% 17 0.1% 2 0.0% . . 2 0.0% 11243 94.6% 11882 100.0%
ASCUS 505 31.8% 431 27.1% 141 8.9% 3 0.2% . . 5 0.3% 504 31.7% 1589 100.0%
LSIL 137 21.6% 278 43.8% 100 15.8% . . . . 1 0.2% 118 18.6% 634 100.0%
Atypical glandular cells/AGC 7 36.8% 4 21.1% . . 2 10.5% 1 5.3% 1 5.3% 4 21.1% 19 100.0%
Unclear atypia . . 2 40.0% . . . . . . . . 3 60.0% 5 100.0%
ASC-H 26 15.7% 53 31.9% 83 50.0% 1 0.6% 1 0.6% . . 2 1.2% 166 100.0%
HSIL 10 4.2% 41 17.2% 175 73.5% 4 1.7% 3 1.3% 1 0.4% 4 1.7% 238 100.0%
Suspected Adenocarcinom . . . . . . 1 50.0% . . . . 1 50.0% 2 100.0%
Adenocarcinoma . . . . . . . . . . . . 1 100.0% 1 100.0%
Malignant tumor with unclear origin . . 1 33.3% . . . . . . 1 33.3% 1 33.3% 3 100.0%
Squamous cell cancer . . . . 2 33.3% . . 3 50.0% . . 1 16.7% 6 100.0%
Totalt 1174 8.1% 939 6.5% 518 3.6% 13 0.1% 8 0.1% 11 0.1% 11882 81.7% 14545 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category
Cancer:
M80503, M80703, M81403